Structural Insights into Phylloquinone (Vitamin K1), Menaquinone (MK4, MK7), and Menadione (Vitamin K3) Binding to VKORC1.
VKORC1
enzymatic assays
membrane
menadione
menaquinones
molecular modeling
phylloquinone
structural interactions
vitamins K
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
01 Jan 2019
01 Jan 2019
Historique:
received:
31
10
2018
revised:
21
12
2018
accepted:
24
12
2018
entrez:
6
1
2019
pubmed:
6
1
2019
medline:
21
3
2019
Statut:
epublish
Résumé
Vitamin K family molecules-phylloquinone (K1), menaquinone (K2), and menadione (K3)-act as γ-glutamyl carboxylase (GGCX)-exclusive cofactors in their hydroquinone state, activating proteins of main importance for blood coagulation in the liver and for arterial calcification prevention and energy metabolism in extrahepatic tissues. Once GGCX is activated, vitamin K is found in the epoxide state, which is then recycled to quinone and hydroquinone states by vitamin K epoxide reductase (VKORC1). Nevertheless, little information is available concerning vitamin K1, K2, or K3 tissue distribution and preferential interactions towards VKORC1. Here we present a molecular modeling study of vitamin K1, menaquinones 4, 7 (MK4, MK7), and K3 structural interactions with VKORC1. VKORC1 was shown to tightly bind vitamins K1 and MK4 in the epoxide and quinone states, but not in the hydroquinone state; five VKORC1 residues were identified as crucial for vitamin K stabilization, and two other ones were essential for hydrogen bond formation. However, vitamin MK7 revealed shaky binding towards VKORC1, induced by hydrophobic tail interactions with the membrane. Vitamin K3 exhibited the lowest affinity with VKORC1 because of the absence of a hydrophobic tail, preventing structural stabilization by the enzyme. Enzymatic activity towards vitamins K1, MK4, MK7, and K3 was also evaluated by in vitro assays, validating our in silico predictions: VKORC1 presented equivalent activities towards vitamins K1 and MK4, but much lower activity with respect to vitamin MK7, and no activity towards vitamin K3. Our results revealed VKORC1's ability to recycle both phylloquinone and some menaquinones, and also highlighted the importance of vitamin K's hydrophobic tail size and membrane interactions.
Identifiants
pubmed: 30609653
pii: nu11010067
doi: 10.3390/nu11010067
pmc: PMC6357001
pii:
doi:
Substances chimiques
Vitamin K 2
11032-49-8
Vitamin K 3
723JX6CXY5
Vitamin K 1
84-80-0
VKORC1 protein, human
EC 1.17.4.4
Vitamin K Epoxide Reductases
EC 1.17.4.4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
J Neurosci. 2003 Jul 2;23(13):5816-26
pubmed: 12843286
Nature. 2004 Feb 5;427(6974):537-41
pubmed: 14765194
Nature. 2004 Feb 5;427(6974):541-4
pubmed: 14765195
Clin Pediatr (Phila). 2004 Jun;43(5):499-502
pubmed: 15208761
Trends Biochem Sci. 2004 Jun;29(6):289-92
pubmed: 15276181
J Biol Chem. 2005 Apr 22;280(16):16410-6
pubmed: 15716279
J Comput Chem. 2005 Dec;26(16):1701-18
pubmed: 16211538
Thromb Haemost. 2005 Oct;94(4):780-6
pubmed: 16270630
Antioxid Redox Signal. 2006 Mar-Apr;8(3-4):347-53
pubmed: 16677080
Biochem J. 1935 Jun;29(6):1273-85
pubmed: 16745789
Biochemistry. 2007 Jun 19;46(24):7279-83
pubmed: 17523679
Vitam Horm. 2008;78:35-62
pubmed: 18374189
Vitam Horm. 2008;78:103-30
pubmed: 18374192
J Comput Chem. 2009 Dec;30(16):2785-91
pubmed: 19399780
Br J Nutr. 2009 Oct;102(8):1171-8
pubmed: 19450370
Nature. 2010 Jan 28;463(7280):507-12
pubmed: 20110994
J Biol Chem. 2011 Mar 4;286(9):7267-78
pubmed: 20978134
J Chem Inf Model. 2011 Jan 24;51(1):69-82
pubmed: 21117705
Biochim Biophys Acta. 1990 May 16;1034(2):170-5
pubmed: 2112953
J Phys Chem B. 2012 Mar 15;116(10):3164-79
pubmed: 22352995
J Biol Chem. 2012 Oct 5;287(41):33945-55
pubmed: 22923610
J Thromb Haemost. 2012 Dec;10(12):2535-43
pubmed: 23039877
J Chem Theory Comput. 2012 Sep 11;8(9):3257-3273
pubmed: 23341755
Br J Nutr. 2013 Oct;110(8):1357-68
pubmed: 23590754
Blood. 2013 Oct 10;122(15):2743-50
pubmed: 23982176
J Biol Chem. 2013 Nov 15;288(46):33071-80
pubmed: 24085302
J Thromb Haemost. 2014 Jan;12(1):112-4
pubmed: 24406068
Nat Commun. 2014;5:3110
pubmed: 24477003
Mol Nutr Food Res. 2014 Aug;58(8):1620-35
pubmed: 24668744
J Chem Inf Model. 2014 Jul 28;54(7):1951-62
pubmed: 24850022
J Thromb Haemost. 2016 Feb;14(2):236-47
pubmed: 26663892
Biochem J. 2016 Apr 1;473(7):851-8
pubmed: 26772871
Nat Struct Mol Biol. 2017 Jan;24(1):69-76
pubmed: 27918545
Nat Struct Mol Biol. 2017 Jan;24(1):77-85
pubmed: 27941861
Ecol Evol. 2017 Mar 21;7(8):2767-2776
pubmed: 28428867
Biochem Biophys Res Commun. 1988 Sep 30;155(3):1248-54
pubmed: 3140805
J Lipid Res. 1972 May;13(3):364-70
pubmed: 5025467
Arch Biochem Biophys. 1970 Dec;141(2):473-6
pubmed: 5497142
Biochem Pharmacol. 1995 Jun 16;49(12):1801-7
pubmed: 7598742
Biochemistry. 1995 Jul 25;34(29):9541-51
pubmed: 7626624
Cytokine. 1995 Apr;7(3):287-90
pubmed: 7640347
Bone. 1995 Feb;16(2):179-84
pubmed: 7756045
Biochem Pharmacol. 1993 Oct 19;46(8):1355-62
pubmed: 8240383
Annu Rev Nutr. 1995;15:399-417
pubmed: 8527227
Br J Nutr. 1996 Jan;75(1):121-7
pubmed: 8785182
Jpn J Pharmacol. 1997 Oct;75(2):135-43
pubmed: 9414028